Ultragenyx Pharma (NASDAQ: RARE) disclosed in an SEC filing:On June 10, 2016, Sunil Agarwal gave notice ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE